Current Studies

CURRENT STUDIES


Artificial Pancreas

Tandem Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial   
(Detailed Study Information)
 
Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index
(Detailed Study Information)
 
The International Diabetes Closed Loop (iDCL) Trial: Main Protocol (iDCL Main)
(Detailed Study Information)
 
International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol
 (Detailed Study Information)

If you would like to be in an AP study, please contact:
 
Laura Lindsey
llindsey@sansum.org
805-682-7640 ext. 221
 

Innovation Studies

Abbott FreeStyle Libre Flash Glucose Monitoring System Accuracy Study 
(Detailed Study Information)
 
Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)
(Detailed Study Information)
 
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes (onset®8)
 (Detailed Study Information)
 
A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus
(Detailed Study Information)

If you would like to be in one of these studies, please contact:
 
Contact:
Donna Frase
dfrase@sansum.org
805-682-7640 ext 255

All clinical trials are conducted at our site in Santa Barbara, California. To participate, you will need to come to our site in person. Eligibility for a clinical trial is determined by the study investigator and/or research coordinator. All research is approved by an Institutional Review Board (IRB). Details of many studies can be found on www.clinicaltrials.gov.